Clinical Research Institute of Michigan – Shores Rheumatology
Main: 586-598-3329
Study Coordinator: Amelia Laurence 586-598-3329 X 201
Study Coordinator: Latrece Keaton 586-598-3329 X 202
- Indication: ANCA- Associated Vasculitis
- Enrollment Status: Open
- Protocol: AMG569 20220159
- Drug: Avacopan vs. Placebo
- Sponsor: Amgen
- Description: A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Participants With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis